Ophthalmic Eye Drops Market
Market Insights on Ophthalmic Eye Drops covering sales outlook, demand forecast & up-to-date key trends
Ophthalmic Eye Drops Market by Drug Class (Anesthetic Drops, Dilation Drops, Glaucoma Drops, Steroid Drops, Antibiotic Drops, Others), Indication (Dry Eye, Eye Allergy, Glaucoma, Eye Infection), Drug Formulation, Container Type, Distribution Channel & Region - Forecast to 2020-2030
About the Report
Ophthalmic eye drops are used to deliver medications locally in the ocular cavities to treat ocular conditions or regain normal eye function. The most common and easiest route of ocular drug administration, representing the treatment of choice, is topical instillation of eye drops. The prevalence and incidence and eye infections is expected to rise globally. Emergence of new pathogens, increasing number of post-operative eye infections and poor eye hygiene are likely to boost the global ophthalmic eye drops market.
In its new study, ESOMAR-certified market research and consulting firm Future Market Insights (FMI) offers insights about key factors driving the demand for ophthalmic eye drops. The report tracks the global sales of ophthalmic eye drops in 20+ high-growth markets, along with analyzing the impact COVID-19 has had on the pharmaceutical industry in general, and ophthalmic eye drops in particular.
Let us know your requirement to get
100% FREE customization
How does Historic and Future Outlook for Ophthalmic Eye Drops Market Compare?
One of the significant types of eye infection is post-operative ocular infection. This risk of infection is associated with various ocular surgical conditions which demand eye surgeries. Rising number of ocular surgical conditions has increased the demand for post-operative ocular anti-infective therapies. Ocular surgical conditions such as cataracts, glaucoma, age-related macular degeneration (AMD) and diabetic retinopathy are growing due to aging population and sedentary lifestyle habits. This is creating a huge opportunity for the ophthalmic eye drops market.
For instance, cataracts affect more than 24.4 million Americans aged 40 and older. By age 75, approximately half of all Americans have cataracts. Also, diabetic retinopathy affects nearly 7.7 million Americans aged 40 and older.
Similarly, in the United States, there were 48,229 corneal transplants performed in 2013. Since 1961, more than 1,000,000 men, women and children ranging in age from nine days to 100+ years, have had their sight restored through a corneal transplant.
According to FMI’s analysis, ophthalmic eye drops sales have grown from US$ 12.02 Bn in 2015 to US$14.17BMn in 2019.
The outbreak of COVID19 has disturbed many industries with lockdowns imposed after the outbreak. Industries and economies were affected by the mass spread of the infection, resulting in recession due to the closing down of the offices, factories and markets. As a result, the demand and supply of ophthalmic eye drops was halted, leading to a great loss to the growth of the ophthalmic eye drops market.
The global focus of research and development (R&D) shifted onto the development of the COVID-19 vaccine. As a result, the majority of the research funds and investments were channeled towards COVID-19 vaccine development. However, the ophthalmic eye drops demand is expected to grow from the current dip in the growth trend, with the reopening of the economies and markets.
FMI expects global ophthalmic eye drops demand to grow at 4.1% CAGR through 2030.
How will Initiatives in Creating Awareness Influence Ophthalmic Eye Drops Demand?
The World Health Organization (WHO) and international associations in the field of eye health are actively addressing the care for eye health and accelerating the awareness, diagnosis and treatment of several eye conditions, including eye infections.
For instance, VISION 2020 is a global initiative created by the International Agency for the Prevention of Blindness (IAPB) and the World Health Organization (WHO) in 1999 aimed at eliminating preventable or avoidable eye diseases by the year 2020. In order to reach this goal, VISION 2020 acts to facilitate the development and implementation of sustainable national eye-care programs based on three foundations: human resource development, cost-effective disease control, and infrastructure and technology, and principles of primary health care delivery.
The final objective of VISION 2020 is to integrate a sustainable, comprehensive, high-quality, and equitable eye care system into national health-care systems. In addition, in countries like India, surgeries of cataracts are mostly offered for free via various government programs in the country to the section that falls short of financial aid.
Find your sweet spots for generating winning opportunities in this market.
Talk to AnalystHow will Technological Advancements Affect Ophthalmic Eye Drops Sales?
Eye infections can be caused by several pathogens, including bacteria, amoeba, viruses, and fungi. Bacterial and viral conjunctivitis are highly contagious and may result from a number of common agents, including adenovirus, rubella, herpes, staphylococcus aureus, measles, and streptococcus pneumoniae, among others.
Currently ~60% of patients in the U.S. are prescribed antibiotic eye drops, even though antibiotics are rarely necessary to treat common eye infections. Leading diagnostic industry players are focusing on development and commercialization of rapid point-of-care diagnostic technologies for eye infections. The rapid method is expected to boost the accurate use of anti-infective therapeutics.
For instance, AdenoPlus is a point?of?care diagnostic, a single use test for adenoviral conjunctivitis. The adenovirus serotypes contain a protein called hexon that is detected by AdenoPlus. The test takes around 10 minutes to return a result.
AdenoPlus test is a diagnostic device for acute conjunctivitis and an in vitro diagnostic medical device for which the manufacturer (Rapid Pathogen Screening) received a CE mark in June 2011. The current UK distributor is Nicox Pharma SNC. It is cheaper than the current gold standard PCR test, although PCR is not commonly used because the results are not available in time to guide first?line management.
How is Lack of Awareness Affecting Growth?
The blindness rates in wealthy countries are commonly below 0.5 percent, sometimes much lower. The rate of blindness in many poor countries exceeds 1–2 percent. Reduced acuity that can seriously impair personal functioning, including employment, is at least 6 times more common than blindness. As a result, roughly 30 million people, mostly in the poorer countries of the world, are (to a large degree unnecessarily) blind, and 200 million more are unable to participate fully in the workforce.
Cataracts account for 20 million blind people worldwide, but disproportionately, over 50% of blindness in developing countries. According to the WHO, in 2019, at least 2.2 billion people have vision impairment or blindness, of which over 1 billion cases could have been prevented or have yet to be addressed. Lack of awareness about disease diagnosis and treatment is likely to hamper the market growth.
An unified Market Research Subscription Platform, built for today’s disparate research needs.
Country-wise Insights
How Big is the Opportunity in the US?
In the U.S., the healthcare system is well known for its expenditure and advanced infrastructure. The care regime of the care centers and hospitals are covered by regulations and insurance policies. Government and regulatory bodies of the U.S. are adopting various cost-effective plans to reduce their healthcare burden.
Furthermore, due to the higher prevalence of bacterial and viral diseases, the demand for ophthalmic eye drops is increasing. Adenoviral conjunctivitis results in a large number of physician office visits in the United States and places a great financial burden on health care. It is recorded that the incidence of adenovirus infection is as high as 20 million cases per year in the United States. Nearly a million eye infections that require a trip to the doctor or hospital happen each year, many of them related to contact lens use.
The Centers for Disease Control and Prevention (CDC) reported that more than 2.8 million antibiotic-resistant infections occur in the U.S. each year. The government is putting in place prevention and infection control efforts in the U.S. to reduce the number of infections and deaths caused by antibiotic-resistant germs, but the number of people facing antibiotic resistance is still too high.
How is the Ophthalmic Eye Drops Market of Germany Flourishing?
The German healthcare system is a universal, multi-payer system that is largely funded by the government. It is one of the most successful healthcare systems in the world. It is not surprising that Germany has the highest level of spending in Europe. Furthermore, the presence of several key players, rising prevalence of eye infections, rising technological advancements, and growing R&D in the country creates a huge opportunity for the ophthalmic eye drops market to grow. The Germany ophthalmic eye drops market is expected to reach 982.6 Mn by the end of 2030.
What are the Factors Driving the India Ophthalmic Eye Drops Market?
Increasing investments in the healthcare sector in emerging countries, especially India, is anticipated to boost the demand for ocular infection therapeutics. Increasing promotional and awareness activities and improving healthcare access is expected to provide significant opportunities in the emerging regions for the ophthalmic eye drops market.
Category-wise Insights
Why do Dilation Eye Drops Dominate the Ophthalmic Eye Drops Market?
The demand for dilation eye drops is rising worldwide. Dilation eye drops are used on the majority of patients daily during surgical procedures and diagnostic examinations. They are extremely important in order to get an accurate view of the fundus and retina. Indeed, failure to perform in-depth diagnosis of the eye could cause significant harm to the patient such as failure to diagnose or delay in diagnosis, as well as surgical difficulties due to poor visibility. The dilation eye drops segment is likely to grow with a CAGR of 5.3%.
What is the Share of with Preservative in Drug Formulation?
With preservative segment dominated the ophthalmic eye drops market in revenue terms in 2020 and is projected to reach a market share of 89.2% by 2030 in the forecast period.
Why are Dry Eyes Considered Leading Indication Segment?
The rising prevalence of dry eyes condition makes it the dominant indication segment. Some experts estimated that dry eye affects millions of adults in the United States. The risk of developing dry eye increases with advancing age. Women have a higher prevalence of dry eye compared with men. Currently between 16 million and 49 million Americans have dry eyes. This is between 5-15% of the population.
Which Container Type to lead the Ophthalmic Eye Drops Market?
The adoption of multiple dose container is likely to grow, making it the leading and revenue generating container segment in the market. It is anticipated to grow at a CAGR of 3.8% during the forecast period.
What is the Revenue Share of Institutional Sales?
Institutional sales will continue to grow and dominate the ophthalmic eye drops market during the forecast period. According to FMI, the segment is expected to hold around 60.4% of the market share, in terms of distribution channel, by the end of 2030. Institutional sales hold dominance in terms of revenue owing to the higher flow of patients in hospitals, ophthalmic clinics, community clinics, and others.
Competitive Landscape
Strengthening partnerships with major distributors and long-term contracts with end users of ophthalmic eye drops are key strategies adopted by market players. A number of global players have entered into agreements and collaborations to strengthen their sales footprint, increase profitability and sustain market share as they face stiff competition from other major competitors.
Manufacturers are focusing on the development of customized products for end-use industries. They also have entered into long-term agreements with direct end-users.
Some of the leading companies operating in the ophthalmic eye drops market are:
- Novartis AG
- Bausch & Lomb
- Akorn, Inc.
- Biomedica
- AdvaCare Pharma
- C2 PHARMA
- Kraeber GmbH
- Iskon Remedies
- HANSHIN GROUP
- Berry Global Inc.
- Nolato AB
- Bormioli Pharma
- WG Pro-Manufacturing Inc.
- Gerresheimer AG
- Adelphi Healthcare Packaging
- Aptar Group Inc.
- Amcor Plc.
*The list is not exhaustive, and only for representational purposes. Full competitive intelligence with SWOT analysis available in the report.
Scope of the Report
|
Attribute |
Details |
|
Forecast Period |
2020-2030 |
|
Historical Data Available for |
2015-2019 |
|
Market Analysis |
USD Million for Value and Mn Units for Volume |
|
Key Regions Covered |
North America, Latin America, Europe, East Asia, South Asia, Oceania Middle East & Africa |
|
Key Countries Covered |
US, Canada, Germany, U.K., France, Italy, Spain, Russia, China, Japan, South Korea, India, Thailand, Malaysia, Indonesia, Australia, New Zealand, GCC Countries, and South Africa |
|
Key Segments Covered |
Drug Class, Indication, Drug Formulation, Container Type, Distribution Channel, and Region |
|
Key Companies Profiled |
|
|
Report Coverage |
Market Forecast, Competition Intelligence, DROT Analysis, Market Dynamics and Challenges, Strategic Growth Initiatives |
|
Customization & Pricing |
Ophthalmic Eye Drops Market by Category
Drug Class
- Anesthetic Drops
- Dilation Drops
- Glaucoma Drops
- Steroid Drops
- Antibiotic Drops
- Others (Antihistamine, Lubricants Tear Drops)
Indication
- Dry Eye
- Eye Allergy
- Glaucoma
- Eye Infection
- Retinal Disorders
- Macular Degeneration
- Diabetic Retinopathy
- Others
- Uveitis
- Others
Drug Formulation
- With Preservative
- Preservative Free
Container Type
- Single Dose Container
- Multiple-Dose Container
Distribution Channel
- Institutional Sales
- Hospitals
- Community Clinics
- Ophthalmic Clinics
- Public Health Agencies
- Veterinary Hospitals & Clinics
- Retail Sales
- Retail Pharmacies
- Drug Stores
Region
- North America
- Latin America
- Europe
- East Asia
- South Asia
- Oceania
- Middle East and Africa (MEA)
Frequently Asked Questions
The U.S. currently leads the global market for ophthalmic eye drops. Sales in the U.S. will be around 29% of total global demand throughout the forecast period.
Dilation eye drops are dominating the drug class segment in the ophthalmic eye drops market as compared to other products owing to their high demand.
Some of the leading companies offering ophthalmic eye drops are Novartis AG, Bausch & Lomb, Akorn, Inc., Biomedica, AdvaCare Pharma, C2 PHARMA, Kraeber GmbH, Iskon Remedies, HANSHIN GROUP, Berry Global Inc., Nolato AB, Bormioli Pharma, WG Pro-Manufacturing Inc., Gerresheimer AG, Adelphi Healthcare Packaging, Aptar Group Inc., Acor Plc., and others.
Institutional sales is leading the distribution channel segment of the ophthalmic eye drops demand.
1. Executive Summary
1.1. Global Market Outlook
1.2. Demand Side Trends
1.3. Supply Side Trends
1.4. Technology Roadmap
1.5. Analysis and Recommendations
2. Market Overview
2.1. Market Coverage / Taxonomy
2.2. Market Definition / Scope / Limitations
2.3. Inclusions and Exclusions
3. Key Market Trends
3.1. Key Trends Impacting the Market
3.2. Development Trends
4. Key Success Factors
4.1. Disease Epidemiology, By Regions
4.2. Regulatory & Reimbursement Landscape
4.3. Parent Market Overview
5. Market Background
5.1. Macro-Economic Factors
5.1.1. Global GDP Growth Outlook
5.1.2. Global Healthcare Outlook
5.2. Forecast Factors - Relevance & Impact
5.2.1. Increasing Prevalence of Eye infections and disorders
5.2.2. Treatment Seeking Rate
5.2.3. Product launches
5.2.4. Product Cost
5.3. Market Dynamics
5.3.1. Drivers
5.3.2. Restraints
5.3.3. Opportunity Analysis
6. COVID19 Crisis Impact Analysis
6.1. Current COVID-19 Statistics and Probable Future Impact
6.2. Current GDP Projection and Probable Impact
6.3. Current Economic Projection as compared to 2008 financial analysis
6.4. COVID19 and Impact Analysis
6.5. 2020 Market Scenario
6.6. Recovery Scenario - Short term, Midterm and Long Term Impact
7. Global Ophthalmic Eye Drops Market Volume (Units) Analysis 2015-2019 and Forecast, 2020-2030
7.1. Historical Market Volume (Units) Analysis, 2015-2019
7.2. Current and Future Market Volume (Units) Projections, 2020-2030
7.2.1. Y-o-Y Growth Trend Analysis
8. Global Ophthalmic Eye Drops Market Pricing Analysis
8.1. Regional Pricing Analysis By Product Type
8.2. Pricing Break-up
8.2.1. Manufacturer Level Pricing
8.2.2. Distributor Level Pricing
8.3. Global Average Pricing Analysis Benchmark
9. Global Ophthalmic Eye Drops Market Value (US$ Mn) Analysis 2015-2019 and Forecast, 2020-2030
9.1. Historical Market Value (US$ Mn) Analysis, 2015-2019
9.2. Current and Future Market Value (US$ Mn) Projections, 2020-2030
9.2.1. Y-o-Y Growth Trend Analysis
9.2.2. Absolute $ Opportunity Analysis
10. Global Ophthalmic Eye Drops Market (US$ Mn) & Volume (Units) Analysis 2015-2019 and Forecast 2020-2030, by Drug Class
10.1. Introduction / Key Findings
10.2. Historical Market Size (US$ Mn) & Volume Analysis By Product Type, 2015-2019
10.3. Current and Future Market Size (US$ Mn) & Volume Analysis and Forecast By Drug Class , 2020-2030
10.3.1. Anaesthetic Drops
10.3.2. Dilation Drops
10.3.3. Glaucoma Drops
10.3.4. Steroid Drops
10.3.5. Antibiotic Drops
10.4. Market Attractiveness Analysis By Drug Class
11. Global Ophthalmic Eye Drops Market Analysis 2015-2019 and Forecast 2020-2030, by Drug Formulation
11.1. Introduction / Key Findings
11.2. Historical Market Size (US$ Mn) & Volume Analysis By Drug Formulation, 2015-2019
11.3. Current and Future Market Size (US$ Mn) & Volume Analysis and Forecast By Drug Formulation, 2020-2030
11.3.1. With Preservative
11.3.2. Preservative Free
11.4. Market Attractiveness Analysis By Drug Formulation
12. Global Ophthalmic Eye Drops Market Analysis 2015-2019 and Forecast 2020-2030, by Indication
12.1. Introduction / Key Findings
12.2. Historical Market Size (US$ Mn) Analysis By Indication, 2015-2019
12.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Indication, 2020-2030
12.3.1. Dry Eye
12.3.2. Eye Allergy
12.3.3. Glaucoma
12.3.4. Eye Infection
12.3.5. Retinal Disorders
12.3.5.1. Macular Degeneration
12.3.5.2. Diabetic Retinopathy
12.3.5.3. Others
12.3.6. Uveitis
12.3.7. Others
12.4. Market Attractiveness Analysis By Indication
13. Global Ophthalmic Eye Drops Market (US$ Mn) & Volume (Units) Analysis 2015-2019 and Forecast 2020-2030, by Container Type
13.1. Introduction / Key Findings
13.2. Historical Market Size (US$ Mn) & Volume Analysis By Dosage Container, 2015-2019
13.3. Current and Future Market Size (US$ Mn) & Volume Analysis and Forecast By Container Type, 2020-2030
13.3.1. Single Dose Containers
13.3.2. Multiple-Dose Containers
13.4. Market Attractiveness Analysis By Container Type
14. Global Ophthalmic Eye Drops Market Analysis 2015-2019 and Forecast 2020-2030, by Distribution Channel
14.1. Introduction / Key Findings
14.2. Historical Market Size (US$ Mn) & Volume Analysis By Distribution Channel, 2015-2019
14.3. Current and Future Market Size (US$ Mn) & Volume Analysis and Forecast By Distribution Channel, 2020-2030
14.3.1. Institutional Sales
14.3.1.1. Hospitals
14.3.1.2. Community Clinics
14.3.1.3. Ophthalmic Clinics
14.3.1.4. Public Health Agencies
14.3.1.5. Veterinary Hospitals & Clinics
14.3.2. Retail Sales
14.3.2.1. Retail Pharmacies
14.3.2.2. Drug Stores
14.3.2.3. Mail Order Pharmacy
14.4. Market Attractiveness Analysis By Distribution Channel
15. Global Ophthalmic Eye Drops Market Analysis 2015-2019 and Forecast 2020-2030, by Region
15.1. Introduction / Key Findings
15.2. Historical Market Size (US$ Mn) Analysis By Region, 2015-2019
15.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Region, 2020-2030
15.3.1. North America
15.3.2. Latin America
15.3.3. Europe
15.3.4. South Asia
15.3.5. East Asia
15.3.6. Oceania
15.3.7. MEA
15.4. Market Attractiveness Analysis By Region
16. North America Ophthalmic Eye Drops Market (US$ Mn) & Volume (Units) Analysis 2015-2019 and Forecast 2020-2030
16.1. Introduction
16.2. Historical Market Size (US$ Mn) & Volume (Units) Analysis By Market Taxonomy, 2015-2019
16.3. Current and Future Market Size (US$ Mn) & Volume (Units) Analysis and Forecast By Market Taxonomy, 2020-2030
16.3.1. By Country
16.3.1.1. U.S.
16.3.1.2. Canada
16.3.2. By Drug Class
16.3.3. By Drug Formulation
16.3.4. By Indication
16.3.5. By Container Type
16.3.6. By Distribution Channel
16.4. Market Attractiveness Analysis
16.5. Key Market Participants - Intensity Mapping
16.6. Drivers and Restraints - Impact Analysis
17. Latin America Ophthalmic Eye Drops Market (US$ Mn) & Volume (Units) Analysis 2015-2019 and Forecast 2020-2030
17.1. Introduction
17.2. Historical Market Size (US$ Mn) & Volume (Units) Analysis By Market Taxonomy, 2015-2019
17.3. Current and Future Market Size (US$ Mn) & Volume (Units) Analysis and Forecast By Market Taxonomy, 2020-2030
17.3.1. By Country
17.3.1.1. Brazil
17.3.1.2. Mexico
17.3.1.3. Argentina
17.3.1.4. Rest of Latin America
17.3.2. By Drug Class
17.3.3. By Drug Formulation
17.3.4. By Indication
17.3.5. By Container Type
17.3.6. By Distribution Channel
17.4. Market Attractiveness Analysis
17.5. Key Market Participants - Intensity Mapping
17.6. Drivers and Restraints - Impact Analysis
18. Europe Ophthalmic Eye Drops Market (US$ Mn) & Volume (Units) Analysis 2015-2019 and Forecast 2020-2030
18.1. Introduction
18.2. Historical Market Size (US$ Mn) & Volume (Units) Analysis By Market Taxonomy, 2015-2019
18.3. Current and Future Market Size (US$ Mn) & Volume (Units) Analysis and Forecast By Market Taxonomy, 2020-2030
18.3.1. By Country
18.3.1.1. U.K.
18.3.1.2. Germany
18.3.1.3. Italy
18.3.1.4. Spain
18.3.1.5. France
18.3.1.6. Russia
18.3.1.7. Benelux
18.3.1.8. Rest of Europe
18.3.2. By Drug Class
18.3.3. By Drug Formulation
18.3.4. By Indication
18.3.5. By Container Type
18.3.6. By Distribution Channel
18.4. Market Attractiveness Analysis
18.5. Key Market Participants - Intensity Mapping
18.6. Drivers and Restraints - Impact Analysis
19. South Asia Ophthalmic Eye Drops Market (US$ Mn) & Volume (Units) Analysis 2015-2019 and Forecast 2020-2030
19.1. Introduction
19.2. Historical Market Size (US$ Mn) & Volume (Units) Analysis By Market Taxonomy, 2015-2019
19.3. Current and Future Market Size (US$ Mn) & Volume (Units) Analysis and Forecast By Market Taxonomy, 2020-2030
19.3.1. By Country
19.3.1.1. India
19.3.1.2. Thailand
19.3.1.3. Indonesia
19.3.1.4. Malaysia
19.3.1.5. Rest of South Asia
19.3.2. By Drug Class
19.3.3. By Drug Formulation
19.3.4. By Indication
19.3.5. By Container Type
19.3.6. By Distribution Channel
19.4. Market Attractiveness Analysis
19.5. Key Market Participants - Intensity Mapping
19.6. Drivers and Restraints - Impact Analysis
20. East Asia Ophthalmic Eye Drops Market (US$ Mn) & Volume (Units) Analysis 2015-2019 and Forecast 2020-2030
20.1. Introduction
20.2. Historical Market Size (US$ Mn) & Volume (Units) Analysis By Market Taxonomy, 2015-2019
20.3. Current and Future Market Size (US$ Mn) & Volume (Units) Analysis and Forecast By Market Taxonomy, 2020-2030
20.3.1. By Country
20.3.1.1. China
20.3.1.2. Japan
20.3.1.3. South Korea
20.3.2. By Drug Class
20.3.3. By Drug Formulation
20.3.4. By Indication
20.3.5. By Container Type
20.3.6. By Distribution Channel
20.4. Market Attractiveness Analysis
20.5. Key Market Participants - Intensity Mapping
20.6. Drivers and Restraints - Impact Analysis
21. Oceania Ophthalmic Eye Drops Market (US$ Mn) & Volume (Units) Analysis 2015-2019 and Forecast 2020-2030
21.1. Introduction
21.2. Historical Market Size (US$ Mn) & Volume (Units) Analysis By Market Taxonomy, 2015-2019
21.3. Current and Future Market Size (US$ Mn) & Volume (Units) Analysis and Forecast By Market Taxonomy, 2020-2030
21.3.1. By Country
21.3.1.1. Australia
21.3.1.2. New Zealand
21.3.2. By Drug Class
21.3.3. By Drug Formulation
21.3.4. By Indication
21.3.5. By Container Type
21.3.6. By Distribution Channel
21.4. Market Attractiveness Analysis
21.5. Key Market Participants - Intensity Mapping
21.6. Drivers and Restraints - Impact Analysis
22. MEA Ophthalmic Eye Drops Market (US$ Mn) & Volume (Units) Analysis 2015-2019 and Forecast 2020-2030
22.1. Introduction
22.2. Historical Market Size (US$ Mn) & Volume (Units) Analysis By Market Taxonomy, 2015-2019
22.3. Current and Future Market Size (US$ Mn) & Volume (Units) Analysis and Forecast By Market Taxonomy, 2020-2030
22.3.1. By Country
22.3.1.1. GCC
22.3.1.2. South Africa
22.3.1.3. Turkey
22.3.1.4. Rest of MEA
22.3.2. By Drug Class
22.3.3. By Drug Formulation
22.3.4. By Indication
22.3.5. By Container Type
22.3.6. By Distribution Channel
22.4. Market Attractiveness Analysis
22.5. Key Market Participants - Intensity Mapping
22.6. Drivers and Restraints - Impact Analysis
23. Key and Emerging Countries Ophthalmic Eye Drops Market Analysis 2015-2019 and Forecast 2020-2030
23.1. Introduction
23.1.1. Market Value Proportion Analysis, By Key Countries
23.1.2. Global Vs. Country Growth Comparison
23.2. U.S. Ophthalmic Eye Drops Market Analysis
23.2.1. By Drug Class
23.2.2. By Drug Formulation
23.2.3. By Indication
23.2.4. By Container Type
23.2.5. By Distribution Channel
23.3. Canada Ophthalmic Eye Drops Market Analysis
23.3.1. By Drug Class
23.3.2. By Drug Formulation
23.3.3. By Indication
23.3.4. By Container Type
23.3.5. By Distribution Channel
23.4. Brazil Ophthalmic Eye Drops Market Analysis
23.4.1. By Drug Class
23.4.2. By Drug Formulation
23.4.3. By Indication
23.4.4. By Container Type
23.4.5. By Distribution Channel
23.5. Mexico Ophthalmic Eye Drops Market Analysis
23.5.1. By Drug Class
23.5.2. By Drug Formulation
23.5.3. By Indication
23.5.4. By Container Type
23.5.5. By Distribution Channel
23.6. Argentina Ophthalmic Eye Drops Market Analysis
23.6.1. By Drug Class
23.6.2. By Drug Formulation
23.6.3. By Indication
23.6.4. By Container Type
23.6.5. By Distribution Channel
23.7. U.K. Ophthalmic Eye Drops Market Analysis
23.7.1. By Drug Class
23.7.2. By Drug Formulation
23.7.3. By Indication
23.7.4. By Container Type
23.7.5. By Distribution Channel
23.8. Germany Ophthalmic Eye Drops Market Analysis
23.8.1. By Drug Class
23.8.2. By Drug Formulation
23.8.3. By Indication
23.8.4. By Container Type
23.8.5. By Distribution Channel
23.9. Italy Ophthalmic Eye Drops Market Analysis
23.9.1. By Drug Class
23.9.2. By Drug Formulation
23.9.3. By Indication
23.9.4. By Container Type
23.9.5. By Distribution Channel
23.10. France Ophthalmic Eye Drops Market Analysis
23.10.1. By Drug Class
23.10.2. By Drug Formulation
23.10.3. By Indication
23.10.4. By Container Type
23.10.5. By Distribution Channel
23.11. Spain Ophthalmic Eye Drops Market Analysis
23.11.1. By Drug Class
23.11.2. By Drug Formulation
23.11.3. By Indication
23.11.4. By Container Type
23.11.5. By Distribution Channel
23.12. Russia Ophthalmic Eye Drops Market Analysis
23.12.1. By Drug Class
23.12.2. By Drug Formulation
23.12.3. By Indication
23.12.4. By Container Type
23.12.5. By Distribution Channel
23.13. Benelux Ophthalmic Eye Drops Market Analysis
23.13.1. By Drug Class
23.13.2. By Drug Formulation
23.13.3. By Indication
23.13.4. By Container Type
23.13.5. By Distribution Channel
23.14. China Ophthalmic Eye Drops Market Analysis
23.14.1. By Drug Class
23.14.2. By Drug Formulation
23.14.3. By Indication
23.14.4. By Container Type
23.14.5. By Distribution Channel
23.15. Japan Ophthalmic Eye Drops Market Analysis
23.15.1. By Drug Class
23.15.2. By Drug Formulation
23.15.3. By Indication
23.15.4. By Container Type
23.15.5. By Distribution Channel
23.16. South Korea Ophthalmic Eye Drops Market Analysis
23.16.1. By Drug Class
23.16.2. By Drug Formulation
23.16.3. By Indication
23.16.4. By Container Type
23.16.5. By Distribution Channel
23.17. India Ophthalmic Eye Drops Market Analysis
23.17.1. By Drug Class
23.17.2. By Drug Formulation
23.17.3. By Indication
23.17.4. By Container Type
23.17.5. By Distribution Channel
23.18. Indonesia Ophthalmic Eye Drops Market Analysis
23.18.1. By Drug Class
23.18.2. By Drug Formulation
23.18.3. By Indication
23.18.4. By Container Type
23.18.5. By Distribution Channel
23.19. Malaysia Ophthalmic Eye Drops Market Analysis
23.19.1. By Drug Class
23.19.2. By Drug Formulation
23.19.3. By Indication
23.19.4. By Container Type
23.19.5. By Distribution Channel
23.20. ASEAN Ophthalmic Eye Drops Market Analysis
23.20.1. By Drug Class
23.20.2. By Drug Formulation
23.20.3. By Indication
23.20.4. By Distribution Channel
23.21. Australia Ophthalmic Eye Drops Market Analysis
23.21.1. By Drug Class
23.21.2. By Drug Formulation
23.21.3. By Indication
23.21.4. By Container Type
23.21.5. By Distribution Channel
23.22. New Zealand Ophthalmic Eye Drops Market Analysis
23.22.1. By Drug Class
23.22.2. By Drug Formulation
23.22.3. By Indication
23.22.4. By Container Type
23.22.5. By Distribution Channel
23.23. GCC Ophthalmic Eye Drops Market Analysis
23.23.1. By Drug Class
23.23.2. By Drug Formulation
23.23.3. By Indication
23.23.4. By Container Type
23.23.5. By Distribution Channel
23.24. South Africa Ophthalmic Eye Drops Market Analysis
23.24.1. By Drug Class
23.24.2. By Drug Formulation
23.24.3. By Indication
23.24.4. By Container Type
23.24.5. By Distribution Channel
23.25. Turkey Ophthalmic Eye Drops Market Analysis
23.25.1. By Drug Class
23.25.2. By Drug Formulation
23.25.3. By Indication
23.25.4. By Container Type
23.25.5. By Distribution Channel
24. Market Structure Analysis
24.1. Market Analysis by Tier of Companies
24.2. Market Share Analysis of Top Players, By Drug Formulators
24.3. Market Share Analysis of Top Players, By Delivery Systems Manufacturers
24.4. Market Concentration
24.5. Market Presence Analysis
25. Competition Landscape
25.1. Competition Dashboard
25.2. Competition Deep Dive
25.2.1. Finished Product Manufacturers
25.2.1.1. Novartis
25.2.1.1.1. Company Overview
25.2.1.1.2. Product Portfolio
25.2.1.1.3. Sales Footprint
25.2.1.1.4. Strategy Overview
25.2.1.2. Bausch & Lomb
25.2.1.2.1. Company Overview
25.2.1.2.2. Product Portfolio
25.2.1.2.3. Sales Footprint
25.2.1.2.4. Strategy Overview
25.2.1.3. Akorn, Inc.
25.2.1.3.1. Company Overview
25.2.1.3.2. Product Portfolio
25.2.1.3.3. Sales Footprint
25.2.1.3.4. Strategy Overview
25.2.1.4. Biomedica
25.2.1.4.1. Company Overview
25.2.1.4.2. Product Portfolio
25.2.1.4.3. Sales Footprint
25.2.1.4.4. Strategy Overview
25.2.1.5. AdvaCare Pharma
25.2.1.5.1. Company Overview
25.2.1.5.2. Product Portfolio
25.2.1.5.3. Sales Footprint
25.2.1.5.4. Strategy Overview
25.2.1.6. C2 PHARMA
25.2.1.6.1. Company Overview
25.2.1.6.2. Product Portfolio
25.2.1.6.3. Sales Footprint
25.2.1.6.4. Strategy Overview
25.2.1.7. Kraeber GmbH
25.2.1.7.1. Company Overview
25.2.1.7.2. Product Portfolio
25.2.1.7.3. Sales Footprint
25.2.1.7.4. Strategy Overview
25.2.1.8. Iskon Remedies
25.2.1.8.1. Company Overview
25.2.1.8.2. Product Portfolio
25.2.1.8.3. Sales Footprint
25.2.1.8.4. Strategy Overview
25.2.2. OEM
25.2.2.1. HANSHIN GROUP
25.2.2.1.1. Company Overview
25.2.2.1.2. Product Portfolio
25.2.2.1.3. Sales Footprint
25.2.2.1.4. Strategy Overview
25.2.2.2. Berry Global Inc.
25.2.2.2.1. Company Overview
25.2.2.2.2. Product Portfolio
25.2.2.2.3. Sales Footprint
25.2.2.2.4. Strategy Overview
25.2.2.3. Nolato AB
25.2.2.3.1. Company Overview
25.2.2.3.2. Product Portfolio
25.2.2.3.3. Sales Footprint
25.2.2.3.4. Strategy Overview
25.2.2.4. Bormioli Pharma
25.2.2.4.1. Company Overview
25.2.2.4.2. Product Portfolio
25.2.2.4.3. Sales Footprint
25.2.2.4.4. Strategy Overview
25.2.2.5. WG Pro-Manufacturing Inc.
25.2.2.5.1. Company Overview
25.2.2.5.2. Product Portfolio
25.2.2.5.3. Sales Footprint
25.2.2.5.4. Strategy Overview
25.2.2.6. GerresheimerAG
25.2.2.6.1. Company Overview
25.2.2.6.2. Product Portfolio
25.2.2.6.3. Sales Footprint
25.2.2.6.4. Strategy Overview
25.2.2.7. Adelphi Healthcare Packaging
25.2.2.7.1. Company Overview
25.2.2.7.2. Product Portfolio
25.2.2.7.3. Sales Footprint
25.2.2.7.4. Strategy Overview
25.2.2.8. Aptar Group Inc.
25.2.2.8.1. Company Overview
25.2.2.8.2. Product Portfolio
25.2.2.8.3. Sales Footprint
25.2.2.8.4. Strategy Overview
25.2.2.9. Amcor Plc
25.2.2.9.1. Company Overview
25.2.2.9.2. Product Portfolio
25.2.2.9.3. Sales Footprint
25.2.2.9.4. Strategy Overview
26. Assumptions and Acronyms Used
27. Research Methodology
Let us know your requirement to get
100% FREE customization
Table 01: Global Ophthalmic Eye Drops Market Value (US$ Mn) Analysis and Opportunity Assessment 2015–2030, By Drug Class
Table 02: Global Ophthalmic Eye Drops Market Volume (in Mn Units) Analysis and Forecast 2015–2030, By Drug Class
Table 03: Global Ophthalmic Eye Drops Market Value (US$ Mn) Analysis and Opportunity Assessment 2015–2030, By Drug Formulation
Table 04: Global Ophthalmic Eye Drops Market Value (US$ Mn) Analysis and Opportunity Assessment 2015–2030, By Indication
Table 05: Global Ophthalmic Eye Drops Market Value (US$ Mn) Analysis and Opportunity Assessment 2015–2030, By Container Type
Table 06: Global Ophthalmic Eye Drops Market Value (US$ Mn) Analysis and Opportunity Assessment 2015–2030, By Distribution Channel
Table 07: Global Ophthalmic Eye Drops Market Value (US$ Mn) Analysis and Opportunity Assessment 2015–2030, By Region
Table 08: Global Ophthalmic Eye Drops Market Volume (in Mn Units) Analysis and Opportunity Assessment 2015–2030, By Region
Table 09: North America Ophthalmic Eye Drops Market Value (US$ Mn) Analysis and Opportunity Assessment 2015–2030, By Country
Table 10: North America Ophthalmic Eye Drops Market Value (US$ Mn) Analysis and Opportunity Assessment 2015–2030, By Drug Class
Table 11: North America Ophthalmic Eye Drops Market Volume (Mn Units) Analysis and Opportunity Assessment 2015–2030, By Drug Class
Table 12: North America Ophthalmic Eye Drops Market Value (US$ Mn) Analysis and Opportunity Assessment 2015–2030, By Indication
Table 13: North America Ophthalmic Eye Drops Market Value (US$ Mn) Analysis and Opportunity Assessment 2015–2030, By Drug Formulation
Table 14: North America Ophthalmic Eye Drops Market Value (US$ Mn) Analysis and Opportunity Assessment 2015–2030, By Container Type
Table 15: North America Ophthalmic Eye Drops Market Value (US$ Mn) Analysis and Opportunity Assessment 2015–2030, By Distribution Channel
Table 16: Latin America Ophthalmic Eye Drops Market Value (US$ Mn) Analysis and Opportunity Assessment 2015–2030, By Country
Table 17: Latin America Ophthalmic Eye Drops Market Value (US$ Mn) Analysis and Opportunity Assessment 2015–2030, By Drug Class
Table 18: Latin America Ophthalmic Eye Drops Market Volume (Mn Units) Analysis and Opportunity Assessment 2015–2030, By Drug Class
Table 19: Latin America Ophthalmic Eye Drops Market Value (US$ Mn) Analysis and Opportunity Assessment 2015–2030, By Indication
Table 20: Latin America Ophthalmic Eye Drops Market Value (US$ Mn) Analysis and Opportunity Assessment 2015–2030, By Drug Formulation
Table 21: Latin America Ophthalmic Eye Drops Market Value (US$ Mn) Analysis and Opportunity Assessment 2015–2030, By Container Type
Table 22: Latin America Ophthalmic Eye Drops Market Value (US$ Mn) Analysis and Opportunity Assessment 2015–2030, By Distribution Channel
Table 23: Europe Ophthalmic Eye Drops Market Value (US$ Mn) Analysis and Opportunity Assessment 2015–2030, By Country
Table 24: Europe Ophthalmic Eye Drops Market Value (US$ Mn) Analysis and Opportunity Assessment 2015–2030, By Drug Class
Table 25: Europe Ophthalmic Eye Drops Market Volume (Mn Units) Analysis and Opportunity Assessment 2015–2030, By Drug Class
Table 26: Europe Ophthalmic Eye Drops Market Value (US$ Mn) Analysis and Opportunity Assessment 2015–2030, By Indication
Table 27: Europe Ophthalmic Eye Drops Market Value (US$ Mn) Analysis and Opportunity Assessment 2015–2030, By Drug Formulation
Table 28: Europe Ophthalmic Eye Drops Market Value (US$ Mn) Analysis and Opportunity Assessment 2015–2030, By Container Type
Table 29: Europe Ophthalmic Eye Drops Market Value (US$ Mn) Analysis and Opportunity Assessment 2015–2030, By Distribution Channel
Table 30: South Asia Ophthalmic Eye Drops Market Value (US$ Mn) Analysis and Opportunity Assessment 2015–2030, By Country
Table 31: South Asia Ophthalmic Eye Drops Market Value (US$ Mn) Analysis and Opportunity Assessment 2015–2030, By Drug Class
Table 32: South Asia Ophthalmic Eye Drops Market Volume (Mn Units) Analysis and Opportunity Assessment 2015–2030, By Drug Class
Table 33: South Asia Ophthalmic Eye Drops Market Value (US$ Mn) Analysis and Opportunity Assessment 2015–2030, By Indication
Table 34: South Asia Ophthalmic Eye Drops Market Value (US$ Mn) Analysis and Opportunity Assessment 2015–2030, By Drug Formulation
Table 35: South Asia Ophthalmic Eye Drops Market Value (US$ Mn) Analysis and Opportunity Assessment 2015–2030, By Container Type
Table 36: South Asia Ophthalmic Eye Drops Market Value (US$ Mn) Analysis and Opportunity Assessment 2015–2030, By Distribution Channel
Table 37: East Asia Ophthalmic Eye Drops Market Value (US$ Mn) Analysis and Opportunity Assessment 2015–2030, By Country
Table 38: East Asia Ophthalmic Eye Drops Market Value (US$ Mn) Analysis and Opportunity Assessment 2015–2030, By Drug Class
Table 39: East Asia Ophthalmic Eye Drops Market Volume (Mn Units) Analysis and Opportunity Assessment 2015–2030, By Drug Class
Table 40: East Asia Ophthalmic Eye Drops Market Value (US$ Mn) Analysis and Opportunity Assessment 2015–2030, By Indication
Table 41: East Asia Ophthalmic Eye Drops Market Value (US$ Mn) Analysis and Opportunity Assessment 2015–2030, By Drug Formulation
Table 42: East Asia Ophthalmic Eye Drops Market Value (US$ Mn) Analysis and Opportunity Assessment 2015–2030, By Container Type
Table 43: East Asia Ophthalmic Eye Drops Market Value (US$ Mn) Analysis and Opportunity Assessment 2015–2030, By Distribution Channel
Table 44: Oceania Ophthalmic Eye Drops Market Value (US$ Mn) Analysis and Opportunity Assessment 2015–2030, By Country
Table 45: Oceania Ophthalmic Eye Drops Market Value (US$ Mn) Analysis and Opportunity Assessment 2015–2030, By Drug Class
Table 46: Oceania Ophthalmic Eye Drops Market Volume (Mn Units) Analysis and Opportunity Assessment 2015–2030, By Drug Class
Table 47: Oceania Ophthalmic Eye Drops Market Value (US$ Mn) Analysis and Opportunity Assessment 2015–2030, By Indication
Table 48: Oceania Ophthalmic Eye Drops Market Value (US$ Mn) Analysis and Opportunity Assessment 2015–2030, By Drug Formulation
Table 49: Oceania Ophthalmic Eye Drops Market Value (US$ Mn) Analysis and Opportunity Assessment 2015–2030, By Container Type
Table 50: Oceania Ophthalmic Eye Drops Market Value (US$ Mn) Analysis and Opportunity Assessment 2015–2030, By Distribution Channel
Table 51: MEA Ophthalmic Eye Drops Market Value (US$ Mn) Analysis and Opportunity Assessment 2015–2030, By Country
Table 52: MEA Ophthalmic Eye Drops Market Value (US$ Mn) Analysis and Opportunity Assessment 2015–2030, By Drug Class
Table 53: MEA Ophthalmic Eye Drops Market Volume (Mn Units) Analysis and Opportunity Assessment 2015–2030, By Drug Class
Table 54: MEA Ophthalmic Eye Drops Market Value (US$ Mn) Analysis and Opportunity Assessment 2015–2030, By Indication
Table 55: MEA Ophthalmic Eye Drops Market Value (US$ Mn) Analysis and Opportunity Assessment 2015–2030, By Drug Formulation
Table 56: MEA Ophthalmic Eye Drops Market Value (US$ Mn) Analysis and Opportunity Assessment 2015–2030, By Container Type
Table 57: MEA Ophthalmic Eye Drops Market Value (US$ Mn) Analysis and Opportunity Assessment 2015–2030, By Distribution Channel
Find your sweet spots for generating winning opportunities in this market.
Talk to AnalystFigure 01: Global Ophthalmic Eye Drops Market Volume Analysis (Mn Units), 2015-2019
Figure 02: Global Ophthalmic Eye Drops Market Volume Forecast (Mn Units), 2020-2030
Figure 03: Global Ophthalmic Eye Drops Market Value Analysis (US$ Mn), 2015-2019
Figure 04: Global Ophthalmic Eye Drops Market Value Forecast (US$ Mn), 2020-2030
Figure 05: Global Ophthalmic Eye Drops Market Absolute $ Opportunity, 2020 - 2030
Figure 06: Global Ophthalmic Eye Drops Market Share Analysis (%), By Drug Class, 2020-2030
Figure 07: Global Ophthalmic Eye Drops Market Y-o-Y Analysis (%), By Drug Class, 2020-2030
Figure 08: Global Ophthalmic Eye Drops Market Attractiveness Analysis by Drug Class, 2020-2030
Figure 09: Global Ophthalmic Eye Drops Market Share Analysis (%), By Drug Formulation, 2020-2030
Figure 10: Global Ophthalmic Eye Drops Market Y-o-Y Analysis (%), By Drug Formulation, 2020-2030
Figure 11: Global Ophthalmic Eye Drops Market Attractiveness Analysis By Drug Formulation, 2020-2030
Figure 12: Global Ophthalmic Eye Drops Market Share Analysis (%), By Indication, 2020-2030
Figure 13: Global Ophthalmic Eye Drops Market Y-o-Y Analysis (%), By Indication, 2020-2030
Figure 14: Global Ophthalmic Eye Drops Market Attractiveness Analysis By Indication, 2020-2030
Figure 15: Global Ophthalmic Eye Drops Market Share Analysis (%), By Container Type, 2020-2030
Figure 16: Global Ophthalmic Eye Drops Market Y-o-Y Analysis (%), By Container Type, 2020-2030
Figure 17: Global Ophthalmic Eye Drops Market Attractiveness Analysis By Container Type, 2020-2030
Figure 18: Global Ophthalmic Eye Drops Market Share Analysis (%), By Distribution Channel, 2020-2030
Figure 19: Global Ophthalmic Eye Drops Market Y-o-Y Analysis (%), By Distribution Channel, 2020-2030
Figure 20: Global Ophthalmic Eye Drops Market Attractiveness Analysis by Distribution Channel, 2020-2030
Figure 21: Global Ophthalmic Eye Drops Market Share Analysis (%), By Region, 2020-2030
Figure 22: Global Ophthalmic Eye Drops Market Y-o-Y Analysis (%), By Region, 2020-2030
Figure 23: Global Ophthalmic Eye Drops Market Attractiveness Analysis by Region, 2020-2030
Figure 24: North America Ophthalmic Eye Drops Market Value Share, By Drug Class, 2020 (E)
Figure 25: North America Ophthalmic Eye Drops Market Value Share, By Indication, 2020 (E)
Figure 26: North America Ophthalmic Eye Drops Market Value Share, By Drug Formulation, 2020 (E)
Figure 27: North America Ophthalmic Eye Drops Market Value Share, By Container Type, 2020 (E)
Figure 28: North America Ophthalmic Eye Drops Market Value Share, By Distribution Channel, 2020 (E)
Figure 29: North America Ophthalmic Eye Drops Market Value Share, By Country, 2020 (E)
Figure 30: North America Ophthalmic Eye Drops Market Value Analysis (US$ Mn), 2015-2019
Figure 31: North America Ophthalmic Eye Drops Market Value Forecast (US$ Mn), 2020-2030
Figure 32: North America Ophthalmic Eye Drops Market Attractiveness Analysis by Drug Class, 2020-2030
Figure 33: North America Ophthalmic Eye Drops Market Attractiveness Analysis By Indication, 2020-2030
Figure 34: North America Ophthalmic Eye Drops Market Attractiveness Analysis By Drug Formulation, 2020-2030
Figure 35: North America Ophthalmic Eye Drops Market Attractiveness Analysis By Container Type, 2020-2030
Figure 36: North America Ophthalmic Eye Drops Market Attractiveness Analysis by Distribution Channel, 2020-2030
Figure 37: North America Ophthalmic Eye Drops Market Attractiveness Analysis by Country, 2020-2030
Figure 38: Latin America Ophthalmic Eye Drops Market Value Share, By Drug Class, 2020 (E)
Figure 39: Latin America Ophthalmic Eye Drops Market Value Share, By Indication, 2020 (E)
Figure 40: Latin America Ophthalmic Eye Drops Market Value Share, By Drug Formulation, 2020 (E)
Figure 41: Latin America Ophthalmic Eye Drops Market Value Share, By Container Type, 2020 (E)
Figure 42: Latin America Ophthalmic Eye Drops Market Value Share, By Distribution Channel, 2020 (E)
Figure 43: Latin America Ophthalmic Eye Drops Market Value Share, By Country, 2020 (E)
Figure 44: Latin America Ophthalmic Eye Drops Market Value Analysis (US$ Mn), 2015-2019
Figure 45: Latin America Ophthalmic Eye Drops Market Value Forecast (US$ Mn), 2020-2030
Figure 46: Latin America Ophthalmic Eye Drops Market Attractiveness Analysis by Drug Class, 2020-2030
Figure 47: Latin America Ophthalmic Eye Drops Market Attractiveness Analysis By Indication, 2020-2030
Figure 48: Latin America Ophthalmic Eye Drops Market Attractiveness Analysis By Drug Formulation, 2020-2030
Figure 49: Latin America Ophthalmic Eye Drops Market Attractiveness Analysis By Container Type, 2020-2030
Figure 50: Latin America Ophthalmic Eye Drops Market Attractiveness Analysis by Distribution Channel, 2020-2030
Figure 51: Latin America Ophthalmic Eye Drops Market Attractiveness Analysis by Country, 2020-2030
Figure 52: Europe Ophthalmic Eye Drops Market Value Share, By Drug Class, 2020 (E)
Figure 53: Europe Ophthalmic Eye Drops Market Value Share, By Indication, 2020 (E)
Figure 54: Europe Ophthalmic Eye Drops Market Value Share, By Drug Formulation, 2020 (E)
Figure 55: Europe Ophthalmic Eye Drops Market Value Share, By Container Type, 2020 (E)
Figure 56: Europe Ophthalmic Eye Drops Market Value Share, By Distribution Channel, 2020 (E)
Figure 57: Europe Ophthalmic Eye Drops Market Value Share, By Country, 2020 (E)
Figure 58: Europe Ophthalmic Eye Drops Market Value Analysis (US$ Mn), 2015-2019
Figure 59: Europe Ophthalmic Eye Drops Market Value Forecast (US$ Mn), 2020-2030
Figure 60: Europe Ophthalmic Eye Drops Market Attractiveness Analysis by Drug Class, 2020-2030
Figure 61: Europe Ophthalmic Eye Drops Market Attractiveness Analysis By Indication, 2020-2030
Figure 62: Europe Ophthalmic Eye Drops Market Attractiveness Analysis By Drug Formulation, 2020-2030
Figure 63: Europe Ophthalmic Eye Drops Market Attractiveness Analysis By Container Type, 2020-2030
Figure 64: Europe Ophthalmic Eye Drops Market Attractiveness Analysis by Distribution Channel, 2020-2030
Figure 65: Europe Ophthalmic Eye Drops Market Attractiveness Analysis by Country, 2020-2030
Figure 66: South Asia Ophthalmic Eye Drops Market Value Share, By Drug Class, 2020 (E)
Figure 67: South Asia Ophthalmic Eye Drops Market Value Share, By Indication, 2020 (E)
Figure 68: South Asia Ophthalmic Eye Drops Market Value Share, By Drug Formulation, 2020 (E)
Figure 69: South Asia Ophthalmic Eye Drops Market Value Share, By Container Type, 2020 (E)
Figure 70: South Asia Ophthalmic Eye Drops Market Value Share, By Distribution Channel, 2020 (E)
Figure 71: South Asia Ophthalmic Eye Drops Market Value Share, By Country, 2020 (E)
Figure 72: South Asia Ophthalmic Eye Drops Market Value Analysis (US$ Mn), 2015-2019
Figure 73: South Asia Ophthalmic Eye Drops Market Value Forecast (US$ Mn), 2020-2030
Figure 74: South Asia Ophthalmic Eye Drops Market Attractiveness Analysis by Drug Class, 2020-2030
Figure 75: South Asia Ophthalmic Eye Drops Market Attractiveness Analysis By Indication, 2020-2030
Figure 76: South Asia Ophthalmic Eye Drops Market Attractiveness Analysis By Drug Formulation, 2020-2030
Figure 77: South Asia Ophthalmic Eye Drops Market Attractiveness Analysis By Container Type, 2020-2030
Figure 78: South Asia Ophthalmic Eye Drops Market Attractiveness Analysis by Distribution Channel, 2020-2030
Figure 79: South Asia Ophthalmic Eye Drops Market Attractiveness Analysis by Country, 2020-2030
Figure 80: East Asia Ophthalmic Eye Drops Market Value Share, By Drug Class, 2020 (E)
Figure 81: East Asia Ophthalmic Eye Drops Market Value Share, By Indication, 2020 (E)
Figure 82: East Asia Ophthalmic Eye Drops Market Value Share, By Drug Formulation, 2020 (E)
Figure 83: East Asia Ophthalmic Eye Drops Market Value Share, By Container Type, 2020 (E)
Figure 84: East Asia Ophthalmic Eye Drops Market Value Share, By Distribution Channel, 2020 (E)
Figure 85: East Asia Ophthalmic Eye Drops Market Value Share, By Country, 2020 (E)
Figure 86: East Asia Ophthalmic Eye Drops Market Value Analysis (US$ Mn), 2015-2019
Figure 87: East Asia Ophthalmic Eye Drops Market Value Forecast (US$ Mn), 2020-2030
Figure 88: East Asia Ophthalmic Eye Drops Market Attractiveness Analysis by Drug Class, 2020-2030
Figure 89: East Asia Ophthalmic Eye Drops Market Attractiveness Analysis By Indication, 2020-2030
Figure 90: East Asia Ophthalmic Eye Drops Market Attractiveness Analysis By Drug Formulation, 2020-2030
Figure 91: East Asia Ophthalmic Eye Drops Market Attractiveness Analysis By Container Type, 2020-2030
Figure 92: East Asia Ophthalmic Eye Drops Market Attractiveness Analysis by Distribution Channel, 2020-2030
Figure 93: East Asia Ophthalmic Eye Drops Market Attractiveness Analysis by Country, 2020-2030
Figure 94: Oceania Ophthalmic Eye Drops Market Value Share, By Drug Class, 2020 (E)
Figure 95: Oceania Ophthalmic Eye Drops Market Value Share, By Indication, 2020 (E)
Figure 96: Oceania Ophthalmic Eye Drops Market Value Share, By Drug Formulation, 2020 (E)
Figure 97: Oceania Ophthalmic Eye Drops Market Value Share, By Container Type, 2020 (E)
Figure 98: Oceania Ophthalmic Eye Drops Market Value Share, By Distribution Channel, 2020 (E)
Figure 99: Oceania Ophthalmic Eye Drops Market Value Share, By Country, 2020 (E)
Figure 100: Oceania Ophthalmic Eye Drops Market Value Analysis (US$ Mn), 2015-2019
Figure 101: Oceania Ophthalmic Eye Drops Market Value Forecast (US$ Mn), 2020-2030
Figure 102: Oceania Ophthalmic Eye Drops Market Attractiveness Analysis by Drug Class, 2020-2030
Figure 103: Oceania Ophthalmic Eye Drops Market Attractiveness Analysis By Indication, 2020-2030
Figure 104: Oceania Ophthalmic Eye Drops Market Attractiveness Analysis By Drug Formulation, 2020-2030
Figure 105: Oceania Ophthalmic Eye Drops Market Attractiveness Analysis By Container Type, 2020-2030
Figure 106: Oceania Ophthalmic Eye Drops Market Attractiveness Analysis by Distribution Channel, 2020-2030
Figure 107: Oceania Ophthalmic Eye Drops Market Attractiveness Analysis by Country, 2020-2030
Figure 108: MEA Ophthalmic Eye Drops Market Value Share, By Drug Class, 2020 (E)
Figure 109: MEA Ophthalmic Eye Drops Market Value Share, By Indication, 2020 (E)
Figure 110: MEA Ophthalmic Eye Drops Market Value Share, By Drug Formulation, 2020 (E)
Figure 111: MEA Ophthalmic Eye Drops Market Value Share, By Container Type, 2020 (E)
Figure 112: MEA Ophthalmic Eye Drops Market Value Share, By Distribution Channel, 2020 (E)
Figure 113: MEA Ophthalmic Eye Drops Market Value Share, By Country, 2020 (E)
Figure 114: MEA Ophthalmic Eye Drops Market Value Analysis (US$ Mn), 2015-2019
Figure 115: MEA Ophthalmic Eye Drops Market Value Forecast (US$ Mn), 2020-2030
Figure 116: MEA Ophthalmic Eye Drops Market Attractiveness Analysis by Drug Class, 2020-2030
Figure 117: MEA Ophthalmic Eye Drops Market Attractiveness Analysis By Indication, 2020-2030
Figure 118: MEA Ophthalmic Eye Drops Market Attractiveness Analysis By Drug Formulation, 2020-2030
Figure 119: MEA Ophthalmic Eye Drops Market Attractiveness Analysis By Container Type, 2020-2030
Figure 120: MEA Ophthalmic Eye Drops Market Attractiveness Analysis by Distribution Channel, 2020-2030
Figure 121: MEA Ophthalmic Eye Drops Market Attractiveness Analysis by Country, 2020-2030
Figure 122: U.S. Ophthalmic Eye Drops Market Share Analysis (%), by Drug Class, 2020 & 2030
Figure 123: U.S. Ophthalmic Eye Drops Market Share Analysis (%), by Indication, 2020 & 2030
Figure 124: U.S. Ophthalmic Eye Drops Market Share Analysis (%), by Drug Formulation, 2020 & 2030
Figure 125: U.S. Ophthalmic Eye Drops Market Share Analysis (%), by Container Type, 2020 & 2030
Figure 126: U.S. Ophthalmic Eye Drops Market Share Analysis (%), by Distribution Channel, 2020 & 2030
Figure 127: Global Vs. U.S. Growth Comparison
Figure 128: Canada Ophthalmic Eye Drops Market Share Analysis (%), by Drug Class, 2020 & 2030
Figure 129: Canada Ophthalmic Eye Drops Market Share Analysis (%), by Indication, 2020 & 2030
Figure 130: Canada Ophthalmic Eye Drops Market Share Analysis (%), by Drug Formulation, 2020 & 2030
Figure 131: Canada Ophthalmic Eye Drops Market Share Analysis (%), by Container Type, 2020 & 2030
Figure 132: Canada Ophthalmic Eye Drops Market Share Analysis (%), by Distribution Channel, 2020 & 2030
Figure 133: Global Vs. Canada Growth Comparison
Figure 134: Brazil Ophthalmic Eye Drops Market Share Analysis (%), by Drug Class, 2020 & 2030
Figure 135: Brazil Ophthalmic Eye Drops Market Share Analysis (%), by Indication, 2020 & 2030
Figure 136: Brazil Ophthalmic Eye Drops Market Share Analysis (%), by Drug Formulation, 2020 & 2030
Figure 137: Brazil Ophthalmic Eye Drops Market Share Analysis (%), by Container Type, 2020 & 2030
Figure 138: Brazil Ophthalmic Eye Drops Market Share Analysis (%), by Distribution Channel, 2020 & 2030
Figure 139: Global Vs. Brazil Growth Comparison
Figure 140: Mexico Ophthalmic Eye Drops Market Share Analysis (%), by Drug Class, 2020 & 2030
Figure 141: Mexico Ophthalmic Eye Drops Market Share Analysis (%), by Indication, 2020 & 2030
Figure 142: Mexico Ophthalmic Eye Drops Market Share Analysis (%), by Drug Formulation, 2020 & 2030
Figure 143: Mexico Ophthalmic Eye Drops Market Share Analysis (%), by Container Type, 2020 & 2030
Figure 144: Mexico Ophthalmic Eye Drops Market Share Analysis (%), by Distribution Channel, 2020 & 2030
Figure 145: Global Vs. Mexico Growth Comparison
Figure 146: Argentina Ophthalmic Eye Drops Market Share Analysis (%), by Drug Class, 2020 & 2030
Figure 147: Argentina Ophthalmic Eye Drops Market Share Analysis (%), by Indication, 2020 & 2030
Figure 148: Argentina Ophthalmic Eye Drops Market Share Analysis (%), by Drug Formulation, 2020 & 2030
Figure 149: Argentina Ophthalmic Eye Drops Market Share Analysis (%), by Container Type, 2020 & 2030
Figure 150: Argentina Ophthalmic Eye Drops Market Share Analysis (%), by Distribution Channel, 2020 & 2030
Figure 151: Global Vs. Argentina Growth Comparison
Figure 152: U.K. Ophthalmic Eye Drops Market Share Analysis (%), by Drug Class, 2020 & 2030
Figure 153: U.K. Ophthalmic Eye Drops Market Share Analysis (%), by Indication, 2020 & 2030
Figure 154: U.K. Ophthalmic Eye Drops Market Share Analysis (%), by Drug Formulation, 2020 & 2030
Figure 155: U.K. Ophthalmic Eye Drops Market Share Analysis (%), by Container Type, 2020 & 2030
Figure 156: U.K. Ophthalmic Eye Drops Market Share Analysis (%), by Distribution Channel, 2020 & 2030
Figure 157: Global Vs. U.K. Growth Comparison
Figure 158: Germany Ophthalmic Eye Drops Market Share Analysis (%), by Drug Class, 2020 & 2030
Figure 159: Germany Ophthalmic Eye Drops Market Share Analysis (%), by Indication, 2020 & 2030
Figure 160: Germany Ophthalmic Eye Drops Market Share Analysis (%), by Drug Formulation, 2020 & 2030
Figure 161: Germany Ophthalmic Eye Drops Market Share Analysis (%), by Container Type, 2020 & 2030
Figure 162: Germany Ophthalmic Eye Drops Market Share Analysis (%), by Distribution Channel, 2020 & 2030
Figure 163: Global Vs. Germany Growth Comparison
Figure 164: Italy Ophthalmic Eye Drops Market Share Analysis (%), by Drug Class, 2020 & 2030
Figure 165: Italy Ophthalmic Eye Drops Market Share Analysis (%), by Indication, 2020 & 2030
Figure 166: Italy Ophthalmic Eye Drops Market Share Analysis (%), by Drug Formulation, 2020 & 2030
Figure 167: Italy Ophthalmic Eye Drops Market Share Analysis (%), by Container Type, 2020 & 2030
Figure 168: Italy Ophthalmic Eye Drops Market Share Analysis (%), by Distribution Channel, 2020 & 2030
Figure 169: Global Vs. Italy Growth Comparison
Figure 170: France Ophthalmic Eye Drops Market Share Analysis (%), by Drug Class, 2020 & 2030
Figure 171: France Ophthalmic Eye Drops Market Share Analysis (%), by Indication, 2020 & 2030
Figure 172: France Ophthalmic Eye Drops Market Share Analysis (%), by Drug Formulation, 2020 & 2030
Figure 173: France Ophthalmic Eye Drops Market Share Analysis (%), by Container Type, 2020 & 2030
Figure 174: France Ophthalmic Eye Drops Market Share Analysis (%), by Distribution Channel, 2020 & 2030
Figure 175: Global Vs. France Growth Comparison
Figure 176: Spain Ophthalmic Eye Drops Market Share Analysis (%), by Drug Class, 2020 & 2030
Figure 177: Spain Ophthalmic Eye Drops Market Share Analysis (%), by Indication, 2020 & 2030
Figure 178: Spain Ophthalmic Eye Drops Market Share Analysis (%), by Drug Formulation, 2020 & 2030
Figure 179: Spain Ophthalmic Eye Drops Market Share Analysis (%), by Container Type, 2020 & 2030
Figure 180: Spain Ophthalmic Eye Drops Market Share Analysis (%), by Distribution Channel, 2020 & 2030
Figure 181: Global Vs. Spain Growth Comparison
Figure 182: Russia Ophthalmic Eye Drops Market Share Analysis (%), by Drug Class, 2020 & 2030
Figure 183: Russia Ophthalmic Eye Drops Market Share Analysis (%), by Indication, 2020 & 2030
Figure 184: Russia Ophthalmic Eye Drops Market Share Analysis (%), by Drug Formulation, 2020 & 2030
Figure 185: Russia Ophthalmic Eye Drops Market Share Analysis (%), by Container Type, 2020 & 2030
Figure 186: Russia Ophthalmic Eye Drops Market Share Analysis (%), by Distribution Channel, 2020 & 2030
Figure 187: Global Vs. Russia Growth Comparison
Figure 188: China Ophthalmic Eye Drops Market Share Analysis (%), by Drug Class, 2020 & 2030
Figure 189: China Ophthalmic Eye Drops Market Share Analysis (%), by Indication, 2020 & 2030
Figure 190: China Ophthalmic Eye Drops Market Share Analysis (%), by Drug Formulation, 2020 & 2030
Figure 191: China Ophthalmic Eye Drops Market Share Analysis (%), by Container Type, 2020 & 2030
Figure 192: China Ophthalmic Eye Drops Market Share Analysis (%), by Distribution Channel, 2020 & 2030
Figure 193: Global Vs. China Growth Comparison
Figure 194: Japan Ophthalmic Eye Drops Market Share Analysis (%), by Drug Class, 2020 & 2030
Figure 195: Japan Ophthalmic Eye Drops Market Share Analysis (%), by Indication, 2020 & 2030
Figure 196: Japan Ophthalmic Eye Drops Market Share Analysis (%), by Drug Formulation, 2020 & 2030
Figure 197: Japan Ophthalmic Eye Drops Market Share Analysis (%), by Container Type, 2020 & 2030
Figure 198: Japan Ophthalmic Eye Drops Market Share Analysis (%), by Distribution Channel, 2020 & 2030
Figure 199: Global Vs. Japan Growth Comparison
Figure 200: South Korea Ophthalmic Eye Drops Market Share Analysis (%), by Drug Class, 2020 & 2030
Figure 201: South Korea Ophthalmic Eye Drops Market Share Analysis (%), by Indication, 2020 & 2030
Figure 202: South Korea Ophthalmic Eye Drops Market Share Analysis (%), by Drug Formulation, 2020 & 2030
Figure 203: South Korea Ophthalmic Eye Drops Market Share Analysis (%), by Container Type, 2020 & 2030
Figure 204: South Korea Ophthalmic Eye Drops Market Share Analysis (%), by Distribution Channel, 2020 & 2030
Figure 205: Global Vs. South Korea Growth Comparison
Figure 206: India Ophthalmic Eye Drops Market Share Analysis (%), by Drug Class, 2020 & 2030
Figure 207: India Ophthalmic Eye Drops Market Share Analysis (%), by Indication, 2020 & 2030
Figure 208: India Ophthalmic Eye Drops Market Share Analysis (%), by Drug Formulation, 2020 & 2030
Figure 209: India Ophthalmic Eye Drops Market Share Analysis (%), by Container Type, 2020 & 2030
Figure 210: India Ophthalmic Eye Drops Market Share Analysis (%), by Distribution Channel, 2020 & 2030
Figure 211: Global Vs. India Growth Comparison
Figure 212: Indonesia Ophthalmic Eye Drops Market Share Analysis (%), by Drug Class, 2020 & 2030
Figure 213: Indonesia Ophthalmic Eye Drops Market Share Analysis (%), by Indication, 2020 & 2030
Figure 214: Indonesia Ophthalmic Eye Drops Market Share Analysis (%), by Drug Formulation, 2020 & 2030
Figure 215: Indonesia Ophthalmic Eye Drops Market Share Analysis (%), by Container Type, 2020 & 2030
Figure 216: Indonesia Ophthalmic Eye Drops Market Share Analysis (%), by Distribution Channel, 2020 & 2030
Figure 217: Global Vs. Indonesia Growth Comparison
Figure 218: Malaysia Ophthalmic Eye Drops Market Share Analysis (%), by Drug Class, 2020 & 2030
Figure 219: Malaysia Ophthalmic Eye Drops Market Share Analysis (%), by Indication, 2020 & 2030
Figure 220: Malaysia Ophthalmic Eye Drops Market Share Analysis (%), by Drug Formulation, 2020 & 2030
Figure 221: Malaysia Ophthalmic Eye Drops Market Share Analysis (%), by Container Type, 2020 & 2030
Figure 222: Malaysia Ophthalmic Eye Drops Market Share Analysis (%), by Distribution Channel, 2020 & 2030
Figure 223: Global Vs. Malaysia Growth Comparison
Figure 224: Thailand Ophthalmic Eye Drops Market Share Analysis (%), by Drug Class, 2020 & 2030
Figure 225: Thailand Ophthalmic Eye Drops Market Share Analysis (%), by Indication, 2020 & 2030
Figure 226: Thailand Ophthalmic Eye Drops Market Share Analysis (%), by Drug Formulation, 2020 & 2030
Figure 227: Thailand Ophthalmic Eye Drops Market Share Analysis (%), by Container Type, 2020 & 2030
Figure 228: Thailand Ophthalmic Eye Drops Market Share Analysis (%), by Distribution Channel, 2020 & 2030
Figure 229: Global Vs. Thailand Growth Comparison
Figure 230: Australia Ophthalmic Eye Drops Market Share Analysis (%), by Drug Class, 2020 & 2030
Figure 231: Australia Ophthalmic Eye Drops Market Share Analysis (%), by Indication, 2020 & 2030
Figure 232: Australia Ophthalmic Eye Drops Market Share Analysis (%), by Drug Formulation, 2020 & 2030
Figure 233: Australia Ophthalmic Eye Drops Market Share Analysis (%), by Container Type, 2020 & 2030
Figure 234: Australia Ophthalmic Eye Drops Market Share Analysis (%), by Distribution Channel, 2020 & 2030
Figure 235: Global Vs. Australia Growth Comparison
Figure 236: New Zealand Ophthalmic Eye Drops Market Share Analysis (%), by Drug Class, 2020 & 2030
Figure 237: New Zealand Ophthalmic Eye Drops Market Share Analysis (%), by Indication, 2020 & 2030
Figure 238: New Zealand Ophthalmic Eye Drops Market Share Analysis (%), by Drug Formulation, 2020 & 2030
Figure 239: New Zealand Ophthalmic Eye Drops Market Share Analysis (%), by Container Type, 2020 & 2030
Figure 240: New Zealand Ophthalmic Eye Drops Market Share Analysis (%), by Distribution Channel, 2020 & 2030
Figure 241: Global Vs. New Zealand Growth Comparison
Figure 242: GCC Countries Ophthalmic Eye Drops Market Share Analysis (%), by Drug Class, 2020 & 2030
Figure 243: GCC Countries Ophthalmic Eye Drops Market Share Analysis (%), by Indication, 2020 & 2030
Figure 244: GCC Countries Ophthalmic Eye Drops Market Share Analysis (%), by Drug Formulation, 2020 & 2030
Figure 245: GCC Countries Ophthalmic Eye Drops Market Share Analysis (%), by Container Type, 2020 & 2030
Figure 246: GCC Countries Ophthalmic Eye Drops Market Share Analysis (%), by Distribution Channel, 2020 & 2030
Figure 247: Global Vs. GCC Countries Growth Comparison
Figure 248: South Africa Ophthalmic Eye Drops Market Share Analysis (%), by Drug Class, 2020 & 2030
Figure 249: South Africa Ophthalmic Eye Drops Market Share Analysis (%), by Indication, 2020 & 2030
Figure 250: South Africa Ophthalmic Eye Drops Market Share Analysis (%), by Drug Formulation, 2020 & 2030
Figure 251: South Africa Ophthalmic Eye Drops Market Share Analysis (%), by Container Type, 2020 & 2030
Figure 252: South Africa Ophthalmic Eye Drops Market Share Analysis (%), by Distribution Channel, 2020 & 2030
Figure 253: Global Vs. South Africa Growth Comparison
Figure 254: Turkey Ophthalmic Eye Drops Market Share Analysis (%), by Drug Class, 2020 & 2030
Figure 255: Turkey Ophthalmic Eye Drops Market Share Analysis (%), by Indication, 2020 & 2030
Figure 256: Turkey Ophthalmic Eye Drops Market Share Analysis (%), by Drug Formulation, 2020 & 2030
Figure 257: Turkey Ophthalmic Eye Drops Market Share Analysis (%), by Container Type, 2020 & 2030
Figure 258: Turkey Ophthalmic Eye Drops Market Share Analysis (%), by Distribution Channel, 2020 & 2030
Figure 259: Global Vs. Turkey Growth Comparison
Need specific information?
Request CustomizationExplore Healthcare Insights
View Reports
